Aurora Cannabis Inc. (ACB) vs BridgeBio Oncology Therapeutics Inc. (BBOT)
A side-by-side comparison of Aurora Cannabis Inc. and BridgeBio Oncology Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACB
Aurora Cannabis Inc.
$4.46HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
BBOT
BridgeBio Oncology Therapeutics Inc.
$3.60HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ACB vs BBOT
growth of $100 · dividends reinvested · last 3yACB +2.8% (+0.9%/yr)BBOT -64.7% (-29.3%/yr)ACB compounded faster over this window
ACB BBOT
ACB vs BBOT: by the numbers
- •BBOT is the larger company ($288M vs $276M market cap).
- •Both run net losses; BBOT's is the smaller (0.00% vs -38.13% net margin).
Metrics side by side
Valuation
| Metric | ACB | BBOT |
|---|---|---|
| P/S ratio | 1.33 | N/A |
| P/B ratio | 0.74 | 0.89 |
Profitability
| Metric | ACB | BBOT |
|---|---|---|
| Gross margin | 42.62% | 0.00% |
| Operating margin | -14.55% | 0.00% |
| Net margin | -38.13% | 0.00% |
| ROE | -21.41% | -56.36% |
| ROIC | -15.69% | -61.10% |
Growth (annualized)
| Metric | ACB | BBOT |
|---|---|---|
| Revenue CAGR (5Y) | 1.68% | N/A |
| Total return CAGR (5Y) | -42.83% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.